Uppal Timsy, Khazaieli Amir, Snijders Antoine M, Verma Subhash C
Department of Microbiology and Immunology, Reno School of Medicine, University of Nevada, 1664 N Virginia Street, Reno, NV 89557, USA.
FATHHOME, INC., 8000 Edgewater Drive Suite #200, Oakland, CA 94621, USA.
Pathogens. 2021 Mar 14;10(3):339. doi: 10.3390/pathogens10030339.
The pandemic of SARS-CoV-2/COVID-19 was reported in December 2019 in Wuhan, China. Pertaining to its high transmissibility and wide host adaptability, this unique human coronavirus spread across the planet inflicting 115 million people and causing 2.5 million deaths (as of March 3rd, 2021). Limited or negligible pre-existing immunity to multiple SARS-CoV-2 variants has resulted in severe morbidity and mortality worldwide, as well as a record-breaking surge in the use of medical-surgical supplies and personal protective equipment. In response to the global need for effective sterilization techniques, this study evaluated the virucidal efficacy of FATHHOME's self-contained, ozone-based dry-sanitizing device, by dose and time response assessment. We tested inactivation of human coronavirus, HCoV-OC43, a close genetic model of SARS-CoV-2, on porous (N95 filtering facepiece respirator/FFR) and nonporous (glass) surfaces. We started our assays with 20 ppm-10 min ozone exposure, and effectively reduced 99.8% and 99.9% of virus from glass and N95 FFR surfaces, respectively. Importantly, the virus was completely inactivated, below the detection limit (over 6-log reduction) with 25 ppm-15 min ozone exposure on both tested surfaces. As expected, a higher ozone exposure (50 ppm-10 min) resulted in faster inactivation of HCoV-OC43 with 100% inactivation from both the surfaces, with no residual ozone present after completion of the 5-min post exposure recapture cycle and no measurable increase in ambient ozone levels. These results confirmed that FATHHOME's device is suitable for rapid decontamination of SARS-CoV-2- from worn items, frequently touched items, and PPE including N95 FFRs, face shields, and other personal items.
2019年12月,中国武汉报告了严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)/新型冠状病毒肺炎(COVID-19)疫情。鉴于其高传播性和广泛的宿主适应性,这种独特的人类冠状病毒在全球范围内传播,感染了1.15亿人,造成250万人死亡(截至2021年3月3日)。对多种SARS-CoV-2变体的预先存在的免疫力有限或可忽略不计,导致全球范围内出现严重的发病率和死亡率,以及医用外科用品和个人防护装备的使用量破纪录激增。为满足全球对有效消毒技术的需求,本研究通过剂量和时间响应评估,评估了FATHHOME独立的基于臭氧的干式消毒设备的杀病毒效果。我们测试了人类冠状病毒HCoV-OC43(SARS-CoV-2的密切基因模型)在多孔(N95过滤面罩呼吸器/FFR)和无孔(玻璃)表面上的灭活情况。我们从20 ppm-10分钟的臭氧暴露开始试验,分别有效减少了玻璃表面和N95 FFR表面99.8%和99.9%的病毒。重要的是,在两个测试表面上,25 ppm-15分钟的臭氧暴露使病毒完全失活,低于检测限(超过6个对数级的减少)。正如预期的那样,更高的臭氧暴露(50 ppm-10分钟)导致HCoV-OC43更快失活,两个表面均100%失活,在5分钟的暴露后回收周期结束后没有残留臭氧,并且环境臭氧水平没有可测量的增加。这些结果证实,FATHHOME的设备适用于对包括N95 FFR、面罩和其他个人物品在内的穿戴物品、经常触摸的物品和个人防护装备上的SARS-CoV-2进行快速去污。